Last reviewed · How we verify

NCT04106401: ANTARCV

Intravascular Volumes in Hypoxia During Antarctic Confinement

Status unknown NA Last updated 13 September 2022
What this trial tests

NA trial testing carbon-monoxide rebreathing in Hypoxia in 24 participants. Status unknown.

Timeline
27 September 2019
Primary endpoint
31 December 2022
31 December 2022

Quick facts

Lead sponsorEcole Nationale des Sports de Montagne
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposebasic science
Enrollment24
Start date27 September 2019
Primary completion31 December 2022
Estimated completion31 December 2022
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Ecole Nationale des Sports de Montagne

Who can join

Adults 18 to 65, any sex, with Hypoxia or Confinement. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the effect of hypoxia on blood volumes during Antarctic winter-over confinement. Half of the participants will be evaluated during sea-level winter-over confinement, while the other half will be examined during high-altitude hypoxia winter-over confinement.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hypoxia

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04106401.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing